LumiraDx Ltd (LMDX) - Financial and Strategic SWOT Analysis Review

March 2021 | 39 pages | ID: LFAEAADBA3BBEN
GlobalData

Abstracts

LumiraDx Ltd (LMDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

LumiraDx Ltd (LumiraDx) is a provider of point of care (PoC) diagnostic tests and solutions. Its product portfolio includes severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2) antigen test, SARS-CoV-2 antibody test, INR test and D-Dimmer test. It offers solutions such as engage, a patient program; INRstar, an anticoagulation software; and DataWell, a data-sharing solution. The company’s products are built on its proprietary, LumiraDx platform. LumiraDx is also evaluating pipeline products at various stages development for screening infectious diseases, diabetes and cardiovascular diseases. The company sells its products through direct sales force and a network of distributors in the US, Europe, Japan, South Africa, Colombia and Brazil. LumiraDx is headquartered in London, the UK.

LumiraDx Ltd Key Recent Developments

May 19,2020: Drive through Warfarin Clinic supported by LumiraDx

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

LumiraDx Ltd - Key Facts
LumiraDx Ltd - Key Employees
LumiraDx Ltd - Key Employee Biographies
LumiraDx Ltd - Major Products and Services
LumiraDx Ltd - History
LumiraDx Ltd - Company Statement
LumiraDx Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
LumiraDx Ltd - Business Description
Product Category: Revenue from Contracts with Customers
Performance
Product Category: Revenue from Other Sources
Performance
Product Category: Products
Performance
Product Category: Services
Performance
Product Category: Software
Performance
Geographical Segment: Brazil
Performance
Geographical Segment: Colombia
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Italy
Performance
Geographical Segment: Norway
Performance
Geographical Segment: Other
Performance
Geographical Segment: Sweden
Performance
Geographical Segment: The UK
Performance
Geographical Segment: The US
Performance
R&D Overview
LumiraDx Ltd - Corporate Strategy
LumiraDx Ltd - SWOT Analysis
SWOT Analysis - Overview
LumiraDx Ltd - Strengths
LumiraDx Ltd - Weaknesses
LumiraDx Ltd - Opportunities
LumiraDx Ltd - Threats
LumiraDx Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

LumiraDx Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
LumiraDx Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
LumiraDx Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 19, 2020: Drive through Warfarin Clinic supported by LumiraDx

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

LumiraDx Ltd, Key Facts
LumiraDx Ltd, Key Employees
LumiraDx Ltd, Key Employee Biographies
LumiraDx Ltd, Major Products and Services
LumiraDx Ltd, History
LumiraDx Ltd, Other Locations
LumiraDx Ltd, Subsidiaries
LumiraDx Ltd, Key Competitors
LumiraDx Ltd, Annual Ratios
LumiraDx Ltd, Interim Ratios
LumiraDx Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
LumiraDx Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
LumiraDx Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

LumiraDx Ltd, Performance Chart (2018 - 2019)
LumiraDx Ltd, Ratio Charts
LumiraDx Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
LumiraDx Ltd, Medical Equipment, Deals by Type, 2015 to YTD 2021